AngioTech To Conduct Clinical Trials for VaxSys Vascular Wrap

Vascular access is a necessary procedure for patients with End Stage Renal Disease (ESRD) who will undergo hemodialysis. However, it is estimated that up to 50% of vascular accesses with grafts require repair within one year resulting in significant inconvenience and cost to the patient. Fortunately, new treatment options are being developed to make a vascular access last longer, but your help is needed.
Doctors are now conducting an investigational medical research study evaluating the effectiveness of an investigational product called VaxSys Vascular Wrap™ (also called "Vascular Wrap™). When used in conjunction with a vascular graft to create a vascular access for hemodialysis, it is believed that VaxSys Vascular Wrap™ may aid in making the vascular access last longer before repair is necessary by a physician.

information on the study >> http://www.vascularwraptrial.com/